Status:
COMPLETED
Microembolic Signals and Serum Markers of Neuronal Damage During Transcatheter Aortic Valve Implantation.
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Aortic Stenosis
Eligibility:
All Genders
Brief Summary
Transcatheter Aortic Valve Implantation (TAVI) using femoral access is an option for definitive treatment of aortic stenosis when open-heart surgery is considered inappropriate. By avoiding the effect...
Detailed Description
Patients scheduled for TAVI at our institution are screened for inclusion into this prospective, observational study. A multidisciplinary expert committee evaluate all high-risk patients diagnosed wit...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Aortic stenosis rejected for open-heart surgery.
- \-
Exclusion
- None
- \-
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01237743
Start Date
July 1 2009
End Date
December 1 2010
Last Update
March 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Anaesthesia & Intensive Care,Sahlgrenska University Hospital
Gothenburg, Sweden, 41345